NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: December 31, 2007 (Six months ended December 31, 2007)
Business Overview: NAI operates in two primary segments: private label contract manufacturing for nutritional supplements and branded products (including the "Dr. Cherry Pathway to Healing" line and the "As We Change" catalog). The company is headquartered in San Marcos, California, with significant operations in Europe (NAIE).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 7% year-over-year for the six-month period. Private label contract manufacturing sales dropped 5% due to lower volumes from a key customer (Mannatech). Branded products sales fell 17%, driven by the discontinuation of Dr. Cherry's television program in April 2007, which reduced new customer acquisition.
• Margin Compression: Gross profit margin decreased by 2.0 percentage points to 20.8%. This was attributed to incremental direct and indirect labor costs and a shift in sales mix, partially offset by favorable material mix changes.
• Profitability: Operating income declined 78% to $0.4 million, and net income fell 74% to $0.2 million. The company reported a net loss of $0.18 million for the three months ended December 31, 2007, compared to a net income of $0.55 million in the prior year quarter.
• Cash Flow: Operating cash flow dropped significantly to $2.0 million from $9.6 million in the prior year, largely due to an increase in accounts receivable ($0.6 million usage vs. $8.2 million generation previously).

Outlook, Risks, and Contingencies

• Guidance and Outlook: Management anticipates sales to the largest private label customer will trend toward fiscal 2007 levels in the second half of fiscal 2008. Initial shipments from two new customers are expected in late Q3 or early Q4. Branded product sales are expected to improve during the stronger catalog season in Q3 and Q4.
• Covenant Violation: As of December 31, 2007, the company was not in compliance with its quarterly net after-tax income covenant (requiring at least $1.00 of after-tax net income per quarter). The lender agreed to waive default rights as of the reporting date.
• Internal Controls: Management concluded that disclosure controls and procedures were not effective as of December 31, 2007, due to a material weakness in the process for developing forecasts for the annual goodwill impairment analysis. Remediation efforts are ongoing.
• Customer Concentration: The company faces significant economic dependency. Two customers accounted for 76% of net sales in the three months ended December 31, 2007, and 72% for the six-month period.
• Market Risk: The company is exposed to foreign currency fluctuations (Euro and Swiss Franc). A 10% adverse change in exchange rates would have decreased net income by $0.42 million for the six-month period.

Investor Verification Checklist

• Covenant Compliance: Verify the status of the income covenant waiver and whether the company has returned to compliance in subsequent quarters.
• Customer Concentration: Assess the stability of the top two customers, which represent over 70% of revenue, and the impact of volume fluctuations from Mannatech.
• Internal Control Remediation: Monitor progress on fixing the material weakness regarding goodwill impairment analysis and disclosure controls.
• Branded Product Recovery: Evaluate the success of alternative marketing strategies for the "Pathway to Healing" line following the cessation of the TV program.
• Liquidity Position: Confirm that operating cash flows remain sufficient to cover debt service ($143k/month principal + interest) and capital expenditures without needing to draw on the $7.5 million line of credit.